GSK is seeking an Asset Study Delivery Lead for a 14‑month secondment/FTC to manage end‑to‑end portfolio delivery across TA aligned studies. You will partner with TA teams and external investigators to coordinate submissions, reviews and prioritisation of study proposals, ensuring budget forecasting and timely reporting.
You will oversee coordination with LOC, safety, supply, legal, medical affairs, stats and external investigators, driving performance updates and ensuring adherence to GCP and
#J-18808-Ljbffr
Hybrid Asset Study Portfolio Lead employer: Biopharma Careers
Boehringer Ingelheim UK is an exceptional employer that fosters a collaborative and innovative work culture, providing employees with the opportunity to grow professionally within the dynamic pharmaceutical industry. With a strong emphasis on employee development and well-being, the company offers comprehensive benefits and a supportive environment that encourages meaningful contributions to healthcare advancements.
